Poletajew Sławomir, Braticevici Bogdan, Brisuda Antonín, Cauni Victor, Grygorenko Viacheslav, Lesnyak Martyn-Zenovii, Lisiński Janusz, Persu Cristian, Renk Kacper, Radziszewski Piotr
Medical University of Warsaw, Department of Urology, Warsaw, Poland.
Burghele Clinical Hospital, Department of Urology, Bucharest, Romania.
Cent European J Urol. 2015;68(1):9-14. doi: 10.5173/ceju.2015.01.444. Epub 2014 Dec 17.
Time that passes between an unfavourable diagnosis to a radical cystectomy (RC) affects oncological outcomes in patients with bladder cancer. Unsatisfactory survival of patients after RC in Central Europe can potentially result from this factor.
The aim of this study was to assess the time interval between transurethral resection of the bladder tumor (TURBT) and RC in Central Europe and to identify clinical factors of possible delays. 941 consecutive patients who underwent RC in nine Central European urological centers were enrolled into the study. After the TURBT-RC time was calculated, selected clinical and pathological parameters were tested as potential factors influencing the timing of RC.
On average, RCs were performed 73.8 days after TURBTs (median - 53, range 0-1587). In 238 patients (25.3%) the time exceeded 12 weeks. Patients with muscle-invasive cancer were operated earlier on than patients with nonmuscle-invasive cancer (67.6 vs.105.2 days, RR = 1.41, p = 0.00). In high volume centers (>30 RC per year) longer TURBT-RC intervals were observed (97.6 vs. 66.3 days, RR = 2.49, p = 0.00). Simultaneously, factors such as female sex (RR = 1.21), more advanced age of patient (>65 years, RR = 1.23), presence of concomitant CIS (RR = 2.43), grade of cancer cells (RR = 1.67) and final post-RC stage (RR = 1.51) had no statistically significant effect on the results (p >0.05).
The mean time interval between the diagnosis and radical treatment of patients with bladder cancer in Central Europe is adequate. However, there are still a relatively high number of patients waiting for radical cystectomy longer than 8 weeks. A lower stage of disease as well as a higher case load within of a hospital may delay the surgery.
从不良诊断到根治性膀胱切除术(RC)之间所经历的时间会影响膀胱癌患者的肿瘤学结局。中欧地区患者根治性膀胱切除术后生存率不尽人意可能源于这一因素。
本研究旨在评估中欧地区经尿道膀胱肿瘤切除术(TURBT)与根治性膀胱切除术之间的时间间隔,并确定可能导致延迟的临床因素。连续纳入了在九个中欧泌尿外科中心接受根治性膀胱切除术的941例患者。计算出TURBT-RC时间后,对选定的临床和病理参数进行检测,以确定其是否为影响根治性膀胱切除术时机的潜在因素。
平均而言,根治性膀胱切除术在经尿道膀胱肿瘤切除术后73.8天进行(中位数为53天,范围为0-1587天)。238例患者(25.3%)的时间超过了12周。肌层浸润性癌患者比非肌层浸润性癌患者更早接受手术(67.6天对105.2天,RR = 1.41,p = 0.00)。在高手术量中心(每年>30例根治性膀胱切除术),观察到更长的TURBT-RC间隔时间(97.6天对66.3天,RR = 2.49,p = 0.00)。同时,女性性别(RR = 1.21)、患者年龄较大(>65岁,RR = 1.23)、合并原位癌(RR = 2.43)、癌细胞分级(RR = 1.67)和根治性膀胱切除术后最终分期(RR = 1.51)等因素对结果无统计学显著影响(p>0.05)。
中欧地区膀胱癌患者从诊断到根治性治疗的平均时间间隔是合适的。然而,仍有相当数量的患者等待根治性膀胱切除术的时间超过8周。疾病分期较低以及医院内病例数量较多可能会延迟手术。